New treatment approved for advanced breast cancer Dr. Kamal Kant Kohli Kohli8 Oct 2017 9:45 AM ISTNew Treatment with Verzenio (abemaciclib) has been approved by FDA to treat adult patients who have hormone receptor (HR)-positive, human epidermal...
FDA approves new treatment to prevent bleeding in patients of hemophilia A Anjali Nimesh Nimesh20 Nov 2017 7:00 PM ISTThe U.S. Food and Drug Administration approved Hemlibra (emicizumab) to prevent or reduce the frequency of bleeding episodes in adult and pediatric...
FDA approves Sunitinib malate for reduction of risk of kidney cancer after nepherectomy Anjali Nimesh Nimesh26 Nov 2017 7:00 PM ISTThe U.S. Food and Drug Administration approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of kidney...
FDA approves first treatment for breast cancer with a certain inherited genetic mutation Anjali Nimesh Nimesh15 Jan 2018 7:28 PM ISTThe U.S. Food and Drug Administration expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types...
FDA approves new treatment for certain digestive tract cancers Anjali Nimesh Nimesh27 Jan 2018 8:15 PM ISTThe U.S. Food and Drug Administration approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or...
Dabrafenib, Trametinib combo approved for Anaplastic thyroid cancer Anjali Nimesh Nimesh5 May 2018 7:05 PM ISTFDA has approved first treatment for patients with this aggressive form of thyroid cancer, anaplastic thyroid cancer (ATC) that cannot be removed by...
FDA approves Doptelet for thrombocytopenia patients with chronic liver disease Medha Baranwal Baranwal22 May 2018 7:20 PM ISTThe U.S. Food and Drug Administration (FDA) has given its approval to Dova Pharmaceuticals's Doptelet (avatrombopag), a thrombopoietin (TPO) receptor...
New treatment for hairy cell leukemia approved by FDA Hina Zahid14 Sept 2018 7:15 PM ISTNew treatment for hairy cell leukemia has been approved by US FDA, U.S. Food and Drug Administration.Lumoxiti (moxetumomab pasudotox-tdfk) injection...
FDA approves first drug for advanced cutaneous squamous cell carcinoma Hina Zahid1 Oct 2018 7:28 PM ISTFDA approves first treatment specifically for advanced cutaneous squamous cell carcinoma.The U.S. Food and Drug Administration has approved Libtayo...
First treatment of rare immune disease approved by FDA Hina Zahid21 Nov 2018 7:15 PM ISTThe U.S. Food and Drug Administration has approved Gamifant(emapalumab-lzsg) which is a first drug specifically for a rare immune disease primary...
FDA approves first therapy for rare blood clotting disorder Hina Zahid6 Feb 2019 7:25 PM ISTThe U.S. Food and Drug Administration has approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated for the treatment...
FDA approves first targeted therapy for metastatic bladder cancer Hina Zahid15 April 2019 7:05 PM ISTThe U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally...
